Diprion similis isolate iyDipSimi1 chromosome 11, iyDipSimi1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Tenthredinoidea; Diprionidae; Diprioninae; Diprion.
REFSEQ INFORMATION: The reference sequence is identical to\nCM037729.1.\nAssembly name: iyDipSimi1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the United States Department of\nAgriculture on 2021/12/10. The original whole-genome shotgun\nproject has the accession JAJNQI000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: United States Department of Agriculture\nAssembly Date :: 17-NOV-2021\nAssembly Method :: HiFiASM v. 0.16.1-r375; Juicebox Assembly\n Toolkit v. 1.11\nAssembly Name :: iyDipSimi1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100.0x\nSequencing Technology :: PacBio Sequel; Illumina NovaSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Diprion similis Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Catherine Linnen, University of Kentucky
Derived by automated computational analysis using gene prediction method: Gnomon.
fat-like cadherin-related tumor suppressor homolog, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
fat-like cadherin-related tumor suppressor homolog, transcript variant X3
fat-like cadherin-related tumor suppressor homolog, transcript variant X6
fat-like cadherin-related tumor suppressor homolog, transcript variant X5
fat-like cadherin-related tumor suppressor homolog, transcript variant X2
fat-like cadherin-related tumor suppressor homolog, transcript variant X1
fat-like cadherin-related tumor suppressor homolog isoform X4
fat-like cadherin-related tumor suppressor homolog isoform X3
fat-like cadherin-related tumor suppressor homolog isoform X6
fat-like cadherin-related tumor suppressor homolog isoform X5
fat-like cadherin-related tumor suppressor homolog isoform X2
fat-like cadherin-related tumor suppressor homolog isoform X1
fat-like cadherin-related tumor suppressor homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fat-like cadherin-related tumor suppressor homolog isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
helicase POLQ-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
helicase POLQ-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
helicase POLQ-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
RNA polymerase-associated protein LEO1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glycine-rich cell wall structural protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
sarcoplasmic reticulum histidine-rich calcium-binding protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
arylalkylamine N-acetyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
myrosinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myrosinase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myrosinase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25% coverage of the annotated genomic feature by RNAseq alignments
myrosinase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
myrosinase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
myrosinase 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
beta-1,4-glucuronyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
beta-1,4-glucuronyltransferase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1, transcript variant X3
beta-1,4-glucuronyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
beta-1,4-glucuronyltransferase 1 isoform X2
beta-1,4-glucuronyltransferase 1 isoform X1
beta-1,4-glucuronyltransferase 1 isoform X3
beta-1,4-glucuronyltransferase 1 isoform X4
elongation of very long chain fatty acids protein 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
elongation of very long chain fatty acids protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
elongation of very long chain fatty acids protein 4-like, transcript variant X4
elongation of very long chain fatty acids protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
elongation of very long chain fatty acids protein 4-like
glycine receptor subunit alpha-4, transcript variant X1
glycine receptor subunit alpha-4, transcript variant X2
glycine receptor subunit alpha-4 isoform X1
glycine receptor subunit alpha-4 isoform X2
periodic tryptophan protein 2 homolog, transcript variant X2
periodic tryptophan protein 2 homolog, transcript variant X1
V-type proton ATPase 16 kDa proteolipid subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
eukaryotic translation initiation factor 4 gamma 2, transcript variant X2
eukaryotic translation initiation factor 4 gamma 2, transcript variant X3
eukaryotic translation initiation factor 4 gamma 2, transcript variant X1
eukaryotic translation initiation factor 4 gamma 2 isoform X1
eukaryotic translation initiation factor 4 gamma 2 isoform X2
ankyrin repeat and BTB/POZ domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADP-ribosylation factor-like protein 1, transcript variant X1
ADP-ribosylation factor-like protein 1, transcript variant X2
ADP-ribosylation factor-like protein 1 isoform X1
ADP-ribosylation factor-like protein 1 isoform X2
DNA polymerase delta catalytic subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA polymerase delta catalytic subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA polymerase delta catalytic subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA polymerase delta catalytic subunit isoform X2
DNA polymerase delta catalytic subunit isoform X1
DNA polymerase delta catalytic subunit isoform X3
potassium voltage-gated channel subfamily KQT member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 1 isoform X6
potassium voltage-gated channel subfamily KQT member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily KQT member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 1, transcript variant X3
potassium voltage-gated channel subfamily KQT member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily KQT member 1, transcript variant X5
potassium voltage-gated channel subfamily KQT member 1 isoform X1
potassium voltage-gated channel subfamily KQT member 1 isoform X2
potassium voltage-gated channel subfamily KQT member 1 isoform X3
potassium voltage-gated channel subfamily KQT member 1 isoform X4
potassium voltage-gated channel subfamily KQT member 1 isoform X5
uncharacterized LOC124412618, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC124412618, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized protein LOC124412618 isoform X1
uncharacterized protein LOC124412618 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neurogenic protein mastermind-like, transcript variant X1
neurogenic protein mastermind-like, transcript variant X2
neurogenic protein mastermind-like, transcript variant X3
neurogenic protein mastermind-like, transcript variant X4
neurogenic protein mastermind-like isoform X1
neurogenic protein mastermind-like isoform X2
neurogenic protein mastermind-like isoform X3
neurogenic protein mastermind-like isoform X4
neurogenic protein mastermind-like, transcript variant X5
neurogenic protein mastermind-like, transcript variant X6
neurogenic protein mastermind-like, transcript variant X7
neurogenic protein mastermind-like, transcript variant X8
neurogenic protein mastermind-like isoform X5
neurogenic protein mastermind-like isoform X6
neurogenic protein mastermind-like isoform X7
neurogenic protein mastermind-like isoform X8
heat shock protein 75 kDa, mitochondrial
MOB kinase activator-like 2, transcript variant X4
MOB kinase activator-like 2, transcript variant X2
MOB kinase activator-like 2, transcript variant X1
MOB kinase activator-like 2, transcript variant X3
LARGE xylosyl- and glucuronyltransferase 2-like, transcript variant X3
LARGE xylosyl- and glucuronyltransferase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LARGE xylosyl- and glucuronyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LARGE xylosyl- and glucuronyltransferase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LARGE xylosyl- and glucuronyltransferase 2-like, transcript variant X5
LARGE xylosyl- and glucuronyltransferase 2-like isoform X1
LARGE xylosyl- and glucuronyltransferase 2-like isoform X2
LARGE xylosyl- and glucuronyltransferase 2-like isoform X3
leucine-rich repeat-containing protein 24, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich repeat-containing protein 24, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
growth arrest-specific protein 2-like, transcript variant X3
growth arrest-specific protein 2-like isoform X3
growth arrest-specific protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
growth arrest-specific protein 2-like, transcript variant X1
growth arrest-specific protein 2-like isoform X2
growth arrest-specific protein 2-like isoform X1
28S ribosomal protein S27, mitochondrial-like
coiled-coil domain-containing protein 22 homolog, transcript variant X1
coiled-coil domain-containing protein 22 homolog, transcript variant X2
coiled-coil domain-containing protein 22 isoform X1
coiled-coil domain-containing protein 22 homolog isoform X2
DENN domain-containing protein 5B, transcript variant X5
DENN domain-containing protein 5B, transcript variant X2
DENN domain-containing protein 5B, transcript variant X6
DENN domain-containing protein 5B, transcript variant X1
DENN domain-containing protein 5B, transcript variant X7
DENN domain-containing protein 5B, transcript variant X9
DENN domain-containing protein 5B, transcript variant X3
DENN domain-containing protein 5B, transcript variant X4
DENN domain-containing protein 5B, transcript variant X8
DENN domain-containing protein 5B isoform X6
DENN domain-containing protein 5B isoform X1
DENN domain-containing protein 5B isoform X5
DENN domain-containing protein 5B isoform X2
DENN domain-containing protein 5B isoform X7
DENN domain-containing protein 5B isoform X9
DENN domain-containing protein 5B isoform X3
DENN domain-containing protein 5B isoform X8
DENN domain-containing protein 5B isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
translation factor GUF1 homolog, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1
ADP-ribosylation factor GTPase-activating protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
ubiquitin-protein ligase E3A, transcript variant X1
ubiquitin-protein ligase E3A, transcript variant X2
cyclic AMP response element-binding protein A-like, transcript variant X1
cyclic AMP response element-binding protein A-like, transcript variant X2
cyclic AMP response element-binding protein A-like isoform X1
cyclic AMP response element-binding protein A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
histidine-rich glycoprotein-like, transcript variant X1
histidine-rich glycoprotein-like, transcript variant X2
transient-receptor-potential-like protein
insulin-like growth factor I, adult form
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ras-related and estrogen-regulated growth inhibitor-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Bardet-Biedl syndrome 2 protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Bardet-Biedl syndrome 2 protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Bardet-Biedl syndrome 2 protein homolog isoform X2
Bardet-Biedl syndrome 2 protein homolog isoform X1
zinc finger protein OZF-like, transcript variant X1
zinc finger protein OZF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
gamma-aminobutyric acid receptor alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
farnesol dehydrogenase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
farnesol dehydrogenase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat domain-containing protein 27-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 7
paired box protein 6 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
paired box protein 6 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC124412154 isoform X2
carbonic anhydrase-related protein 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
carbonic anhydrase-related protein 10, transcript variant X2
carbonic anhydrase-related protein 10 isoform X1
carbonic anhydrase-related protein 10 isoform X2
leucine-rich repeat-containing protein 24-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
cardio acceleratory peptide 2b, transcript variant X2
cardio acceleratory peptide 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cardio acceleratory peptide 2b isoform X2
uncharacterized protein LOC124412360 isoform X1
putative mediator of RNA polymerase II transcription subunit 26
malignant T-cell-amplified sequence 1 homolog, transcript variant X1
malignant T-cell-amplified sequence 1 homolog, transcript variant X2
malignant T-cell-amplified sequence 1 homolog isoform X1
malignant T-cell-amplified sequence 1 homolog isoform X2
mitochondrial import inner membrane translocase subunit Tim8
clathrin light chain, transcript variant X5
clathrin light chain, transcript variant X1
clathrin light chain, transcript variant X4
clathrin light chain, transcript variant X3
clathrin light chain, transcript variant X2
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X1
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X2
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X1
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X2
1-acylglycerol-3-phosphate O-acyltransferase Pnpla3, transcript variant X1
1-acylglycerol-3-phosphate O-acyltransferase Pnpla3, transcript variant X2
1-acylglycerol-3-phosphate O-acyltransferase Pnpla3 isoform X1
1-acylglycerol-3-phosphate O-acyltransferase Pnpla3 isoform X2
transcription factor SPT20 homolog, transcript variant X3
transcription factor SPT20 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor SPT20 homolog, transcript variant X2
transcription factor SPT20 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor SPT20 homolog, transcript variant X5
transcription factor SPT20 homolog, transcript variant X4
transcription factor SPT20 homolog isoform X4
transcription factor SPT20 homolog isoform X2
transcription factor SPT20 homolog isoform X3
transcription factor SPT20 homolog isoform X1
transcription factor SPT20 homolog isoform X5
transcription factor SPT20 homolog, transcript variant X7
transcription factor SPT20 homolog isoform X6
sterol regulatory element-binding protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
THAP domain-containing protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
THAP domain-containing protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
THAP domain-containing protein 2-like, transcript variant X3
THAP domain-containing protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
THAP domain-containing protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
THAP domain-containing protein 2-like isoform X1
THAP domain-containing protein 2-like isoform X2
uncharacterized protein LOC124412334 isoform X3
ubiquitin carboxyl-terminal hydrolase 46
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
signal peptidase complex subunit 3, transcript variant X1
signal peptidase complex subunit 3, transcript variant X3
signal peptidase complex subunit 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ionotropic receptor 75a-like, transcript variant X1
ionotropic receptor 75a-like, transcript variant X2
nuclear fragile X mental retardation-interacting protein 1-like
FGFR1 oncogene partner 2 homolog, transcript variant X2
FGFR1 oncogene partner 2 homolog, transcript variant X1
FGFR1 oncogene partner 2 homolog isoform X1
FGFR1 oncogene partner 2 homolog isoform X2
myotubularin-related protein 6, transcript variant X1
myotubularin-related protein 6, transcript variant X2
myotubularin-related protein 6 isoform X1
myotubularin-related protein 6, transcript variant X3
myotubularin-related protein 6 isoform X2
myotubularin-related protein 6 isoform X3
cilia- and flagella-associated protein 97, transcript variant X1
cilia- and flagella-associated protein 97, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cilia- and flagella-associated protein 97 isoform X1
cilia- and flagella-associated protein 97 isoform X2
transmembrane protein 131, transcript variant X5
transmembrane protein 131, transcript variant X4
transmembrane protein 131, transcript variant X2
transmembrane protein 131, transcript variant X1
transmembrane protein 131, transcript variant X3
nucleosome assembly protein 1-like 1, transcript variant X1
nucleosome assembly protein 1-like 1, transcript variant X2
nucleosome assembly protein 1-like 1 isoform X2
nucleosome assembly protein 1-like 1 isoform X1
stromal interaction molecule homolog, transcript variant X2
stromal interaction molecule homolog, transcript variant X1
stromal interaction molecule homolog, transcript variant X3
stromal interaction molecule homolog isoform X1
stromal interaction molecule homolog isoform X3
stromal interaction molecule homolog isoform X2
stromal interaction molecule homolog, transcript variant X4
stromal interaction molecule homolog isoform X4
lutropin-choriogonadotropic hormone receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
lutropin-choriogonadotropic hormone receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
lutropin-choriogonadotropic hormone receptor isoform X2
lutropin-choriogonadotropic hormone receptor isoform X1
uncharacterized LOC124412628, transcript variant X3
uncharacterized LOC124412628, transcript variant X5
alpha-N-acetylgalactosaminidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
alpha-N-acetylgalactosaminidase, transcript variant X3
alpha-N-acetylgalactosaminidase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alpha-N-acetylgalactosaminidase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
alpha-N-acetylgalactosaminidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
alpha-N-acetylgalactosaminidase isoform X1
alpha-N-acetylgalactosaminidase isoform X2
uncharacterized LOC124412628, transcript variant X1
uncharacterized LOC124412628, transcript variant X2
uncharacterized LOC124412628, transcript variant X4
uncharacterized LOC124412628, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
fatty acid hydroxylase domain-containing protein 2, transcript variant X2
fatty acid hydroxylase domain-containing protein 2, transcript variant X1
fatty acid hydroxylase domain-containing protein 2 isoform X2
fatty acid hydroxylase domain-containing protein 2 isoform X1
ethanolamine kinase, transcript variant X5
ethanolamine kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
ethanolamine kinase, transcript variant X1
ethanolamine kinase, transcript variant X2
ethanolamine kinase, transcript variant X3
ethanolamine kinase, transcript variant X6
eukaryotic translation initiation factor 3 subunit M
splicing factor 3A subunit 2, transcript variant X3
splicing factor 3A subunit 2, transcript variant X2
splicing factor 3A subunit 2, transcript variant X1
uncharacterized LOC124412566, transcript variant X2
uncharacterized LOC124412566, transcript variant X1
iduronate 2-sulfatase, transcript variant X1
iduronate 2-sulfatase, transcript variant X2
iduronate 2-sulfatase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ets DNA-binding protein pokkuri, transcript variant X3
ets DNA-binding protein pokkuri, transcript variant X2
ets DNA-binding protein pokkuri, transcript variant X1
ets DNA-binding protein pokkuri isoform X1
ets DNA-binding protein pokkuri isoform X2
single-stranded DNA-binding protein, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: single-stranded DNA-binding protein, mitochondrial
guanine nucleotide exchange factor for Rab-3A-like, transcript variant X2
guanine nucleotide exchange factor for Rab-3A-like, transcript variant X1
guanine nucleotide exchange factor for Rab-3A-like, transcript variant X3
guanine nucleotide exchange factor for Rab-3A-like
uncharacterized LOC124412574, transcript variant X2
uncharacterized LOC124412574, transcript variant X1
uncharacterized protein LOC124412574 isoform X1
uncharacterized protein LOC124412574 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
gem-associated protein 5-like, transcript variant X1
gem-associated protein 5-like, transcript variant X2
uncharacterized LOC124412380, transcript variant X5
uncharacterized LOC124412380, transcript variant X1
uncharacterized LOC124412380, transcript variant X4
uncharacterized LOC124412380, transcript variant X2
uncharacterized LOC124412380, transcript variant X3
uncharacterized protein LOC124412380 isoform X1
uncharacterized protein LOC124412380 isoform X2
uncharacterized protein LOC124412380 isoform X3
uncharacterized protein LOC124412380 isoform X4
uncharacterized protein LOC124412380 isoform X5
probable DNA-directed RNA polymerases I and III subunit RPAC2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
MAP kinase-activating death domain protein, transcript variant X4
MAP kinase-activating death domain protein, transcript variant X10
MAP kinase-activating death domain protein, transcript variant X3
MAP kinase-activating death domain protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MAP kinase-activating death domain protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
MAP kinase-activating death domain protein, transcript variant X2
MAP kinase-activating death domain protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MAP kinase-activating death domain protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
MAP kinase-activating death domain protein isoform X4
MAP kinase-activating death domain protein isoform X10
MAP kinase-activating death domain protein isoform X3
MAP kinase-activating death domain protein isoform X5
MAP kinase-activating death domain protein isoform X9
MAP kinase-activating death domain protein isoform X7
MAP kinase-activating death domain protein isoform X2
MAP kinase-activating death domain protein isoform X1
MAP kinase-activating death domain protein, transcript variant X8
MAP kinase-activating death domain protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
MAP kinase-activating death domain protein isoform X8
MAP kinase-activating death domain protein isoform X6
choline/ethanolaminephosphotransferase 1, transcript variant X6
choline/ethanolaminephosphotransferase 1, transcript variant X3
choline/ethanolaminephosphotransferase 1, transcript variant X2
choline/ethanolaminephosphotransferase 1, transcript variant X4
choline/ethanolaminephosphotransferase 1, transcript variant X1
choline/ethanolaminephosphotransferase 1, transcript variant X5
choline/ethanolaminephosphotransferase 1 isoform X5
39S ribosomal protein L21, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
alkylated DNA repair protein alkB homolog 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
high mobility group protein DSP1-like, transcript variant X4
high mobility group protein DSP1-like, transcript variant X2
high mobility group protein DSP1-like, transcript variant X3
high mobility group protein DSP1-like, transcript variant X1
high mobility group protein DSP1-like isoform X1
high mobility group protein DSP1-like isoform X2
exosome complex component RRP45, transcript variant X2
histone deacetylase complex subunit SAP30 homolog
exosome complex component RRP45, transcript variant X1
exosome complex component RRP45 isoform X1
exosome complex component RRP45 isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
proton-coupled amino acid transporter-like protein pathetic
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase UBR2, transcript variant X2
E3 ubiquitin-protein ligase UBR2, transcript variant X1
E3 ubiquitin-protein ligase UBR2, transcript variant X3
E3 ubiquitin-protein ligase SH3RF3-like, transcript variant X1
E3 ubiquitin-protein ligase SH3RF3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF3-like isoform X1
E3 ubiquitin-protein ligase SH3RF3-like isoform X2
probable ATP-dependent RNA helicase DDX49
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
dolichyl-phosphate beta-glucosyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
dolichyl-phosphate beta-glucosyltransferase, transcript variant X1
dolichyl-phosphate beta-glucosyltransferase isoform X1
dolichyl-phosphate beta-glucosyltransferase isoform X2
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X1
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X2
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X3
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X4
probable phosphorylase b kinase regulatory subunit alpha, transcript variant X5
probable phosphorylase b kinase regulatory subunit alpha isoform X1
probable phosphorylase b kinase regulatory subunit alpha isoform X3
probable phosphorylase b kinase regulatory subunit alpha isoform X2
probable phosphorylase b kinase regulatory subunit alpha isoform X4
39S ribosomal protein L28, mitochondrial, transcript variant X1
39S ribosomal protein L28, mitochondrial, transcript variant X2
39S ribosomal protein L28, mitochondrial isoform X1
39S ribosomal protein L28, mitochondrial isoform X2
low-density lipoprotein receptor-related protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
guanine nucleotide-binding protein subunit alpha homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
DNA repair protein complementing XP-C cells homolog, transcript variant X1
DNA repair protein complementing XP-C cells homolog isoform X1
DNA repair protein complementing XP-C cells homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
DNA repair protein complementing XP-C cells homolog isoform X2
paired mesoderm homeobox protein 2A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
THO complex subunit 2, transcript variant X3
THO complex subunit 2, transcript variant X1
THO complex subunit 2, transcript variant X2
THO complex subunit 2, transcript variant X4
uncharacterized LOC124412314, transcript variant X2
uncharacterized LOC124412314, transcript variant X1
uncharacterized protein LOC124412314 isoform X2
uncharacterized protein LOC124412314 isoform X1
protein scalloped, transcript variant X1
protein scalloped, transcript variant X2
protein scalloped, transcript variant X4
protein scalloped, transcript variant X5
protein scalloped, transcript variant X3
transcriptional enhancer factor TEF-1 isoform X3
transcriptional enhancer factor TEF-1 isoform X2
transcriptional enhancer factor TEF-1 isoform X1
40S ribosomal protein S2, transcript variant X4
post-GPI attachment to proteins factor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
post-GPI attachment to proteins factor 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
post-GPI attachment to proteins factor 2-like, transcript variant X1
post-GPI attachment to proteins factor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
40S ribosomal protein S2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 233 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
40S ribosomal protein S2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 233 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
40S ribosomal protein S2, transcript variant X1
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, transcript variant X2
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, transcript variant X1
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X2
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X1
uncharacterized LOC124412320, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC124412320, transcript variant X2
uncharacterized LOC124412320, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124412320, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 106 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
nose resistant to fluoxetine protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
nose resistant to fluoxetine protein 6-like, transcript variant X2
nose resistant to fluoxetine protein 6-like, transcript variant X1
nose resistant to fluoxetine protein 6-like isoform X2
nose resistant to fluoxetine protein 6-like isoform X1
uncharacterized LOC124412542, transcript variant X1
uncharacterized LOC124412542, transcript variant X2
uncharacterized protein LOC124412542 isoform X1
uncharacterized protein LOC124412542 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
RING finger protein 121, transcript variant X1
RING finger protein 121, transcript variant X2
uncharacterized LOC124412514, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124412514, transcript variant X1
uncharacterized protein LOC124412514 isoform X1
uncharacterized protein LOC124412514 isoform X2
protein kinase C and casein kinase substrate in neurons protein 1, transcript variant X6
protein kinase C and casein kinase substrate in neurons protein 1, transcript variant X1
protein kinase C and casein kinase substrate in neurons protein 1, transcript variant X3
protein kinase C and casein kinase substrate in neurons protein 1, transcript variant X4
protein kinase C and casein kinase substrate in neurons protein 1, transcript variant X5
protein kinase C and casein kinase substrate in neurons protein 1, transcript variant X2
protein kinase C and casein kinase substrate in neurons protein 1 isoform X1
protein kinase C and casein kinase substrate in neurons protein 1 isoform X5
protein kinase C and casein kinase substrate in neurons protein 1 isoform X2
protein kinase C and casein kinase substrate in neurons protein 1 isoform X3
protein kinase C and casein kinase substrate in neurons protein 1 isoform X4
uncharacterized LOC124412287, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC124412287, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized protein LOC124412287 isoform X2
uncharacterized protein LOC124412287 isoform X1
uncharacterized LOC124412405, transcript variant X2
uncharacterized LOC124412405, transcript variant X1
uncharacterized protein LOC124412405 isoform X2
uncharacterized protein LOC124412405 isoform X1
uncharacterized protein PB18E9.04c-like, transcript variant X2
uncharacterized protein PB18E9.04c-like, transcript variant X3
uncharacterized protein PB18E9.04c-like, transcript variant X1
uncharacterized protein PB18E9.04c-like isoform X3
uncharacterized protein PB18E9.04c-like isoform X2
uncharacterized protein PB18E9.04c-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124412606
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 67% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cholecystokinin receptor type A-like, transcript variant X3
cholecystokinin receptor type A-like, transcript variant X2
cholecystokinin receptor type A-like, transcript variant X1
vasopressin V1a receptor-like isoform X3
cholecystokinin receptor type A-like isoform X2
cholecystokinin receptor type A-like isoform X1
tyrosine-protein phosphatase 10D-like, transcript variant X7
tyrosine-protein phosphatase 10D-like isoform X7
tyrosine-protein phosphatase 10D-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tyrosine-protein phosphatase 10D-like, transcript variant X2
tyrosine-protein phosphatase 10D-like, transcript variant X3
tyrosine-protein phosphatase 10D-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tyrosine-protein phosphatase 10D-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
tyrosine-protein phosphatase 10D-like, transcript variant X5
tyrosine-protein phosphatase 10D-like isoform X6
tyrosine-protein phosphatase 10D-like isoform X5
tyrosine-protein phosphatase 10D-like isoform X4
tyrosine-protein phosphatase 10D-like isoform X2
tyrosine-protein phosphatase 10D-like isoform X3
tyrosine-protein phosphatase 10D-like isoform X1
transcriptional regulator ovo, transcript variant X3
transcriptional regulator ovo isoform X3
transcriptional regulator ovo, transcript variant X1
transcriptional regulator ovo, transcript variant X4
transcriptional regulator ovo, transcript variant X2
transcriptional regulator ovo isoform X1
AT-rich interactive domain-containing protein 1B isoform X4
transcriptional regulator ovo isoform X2
glutamine-dependent NAD(+) synthetase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamine-dependent NAD(+) synthetase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamine-dependent NAD(+) synthetase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glutamine-dependent NAD(+) synthetase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
glutamine-dependent NAD(+) synthetase, transcript variant X5
glutamine-dependent NAD(+) synthetase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamine-dependent NAD(+) synthetase isoform X1
glutamine-dependent NAD(+) synthetase isoform X2
glutamine-dependent NAD(+) synthetase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
putative WEB family protein At1g65010, chloroplastic, transcript variant X2
putative WEB family protein At1g65010, chloroplastic, transcript variant X1
putative WEB family protein At1g65010, chloroplastic, transcript variant X3
putative WEB family protein At1g65010, chloroplastic isoform X3
putative WEB family protein At1g65010, chloroplastic isoform X2
putative WEB family protein At1g65010, chloroplastic isoform X1
hyaluronan mediated motility receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 5B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TWiK family of potassium channels protein 7-like
lipid storage droplets surface-binding protein 1-like, transcript variant X1
lipid storage droplets surface-binding protein 1-like, transcript variant X3
lipid storage droplets surface-binding protein 1-like, transcript variant X2
lipid storage droplets surface-binding protein 1-like isoform X2
lipid storage droplets surface-binding protein 1-like isoform X3
uncharacterized LOC124412280, transcript variant X2
uncharacterized LOC124412280, transcript variant X1
tumor necrosis factor receptor superfamily member wengen, transcript variant X2
tumor necrosis factor receptor superfamily member wengen, transcript variant X1
tumor necrosis factor receptor superfamily member wengen isoform X1
tumor necrosis factor receptor superfamily member wengen isoform X2
zinc finger protein ztf-16, transcript variant X5
zinc finger protein ztf-16, transcript variant X3
zinc finger protein ztf-16, transcript variant X2
zinc finger protein ztf-16, transcript variant X1
zinc finger protein ztf-16, transcript variant X4
zinc finger protein ztf-16, transcript variant X6
zinc finger protein ztf-16, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
testis-specific serine/threonine-protein kinase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
RWD domain-containing protein 2B, transcript variant X1
RWD domain-containing protein 2A isoform X1
RWD domain-containing protein 2B, transcript variant X2
RWD domain-containing protein 2B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Bardet-Biedl syndrome 7 protein homolog, transcript variant X1
Bardet-Biedl syndrome 7 protein homolog, transcript variant X3
Bardet-Biedl syndrome 7 protein homolog isoform X1
Bardet-Biedl syndrome 7 protein homolog isoform X3
Bardet-Biedl syndrome 7 protein homolog, transcript variant X2
Bardet-Biedl syndrome 7 protein homolog isoform X2
zinc finger protein 37-like, transcript variant X2
zinc finger protein 37-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
growth arrest and DNA damage-inducible proteins-interacting protein 1
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9
AT-rich interactive domain-containing protein 2, transcript variant X5
AT-rich interactive domain-containing protein 2, transcript variant X8
AT-rich interactive domain-containing protein 2, transcript variant X4
AT-rich interactive domain-containing protein 2, transcript variant X3
AT-rich interactive domain-containing protein 2, transcript variant X1
AT-rich interactive domain-containing protein 2, transcript variant X7
AT-rich interactive domain-containing protein 2, transcript variant X6
AT-rich interactive domain-containing protein 2, transcript variant X2
AT-rich interactive domain-containing protein 2 isoform X7
AT-rich interactive domain-containing protein 2 isoform X5
AT-rich interactive domain-containing protein 2 isoform X6
AT-rich interactive domain-containing protein 2 isoform X8
AT-rich interactive domain-containing protein 2 isoform X4
AT-rich interactive domain-containing protein 2 isoform X3
AT-rich interactive domain-containing protein 2 isoform X2
AT-rich interactive domain-containing protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
serine--tRNA synthetase-like protein Slimp
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dynein axonemal heavy chain 1-like
thyrotropin-releasing hormone receptor-like, transcript variant X2
thyrotropin-releasing hormone receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
thyrotropin-releasing hormone receptor-like isoform X2
thyrotropin-releasing hormone receptor-like isoform X1
paired box protein Pax-6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
paired box protein Pax-6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 11B-like, transcript variant X4
zinc finger CCCH domain-containing protein 11B-like, transcript variant X3
zinc finger CCCH domain-containing protein 11B-like, transcript variant X1
zinc finger CCCH domain-containing protein 11B-like, transcript variant X2
zinc finger CCCH domain-containing protein 11B-like isoform X1
zinc finger CCCH domain-containing protein 11B-like isoform X2
zinc finger CCCH domain-containing protein 11B-like isoform X3
UHRF1-binding protein 1-like, transcript variant X3
UHRF1-binding protein 1-like, transcript variant X2
UHRF1-binding protein 1-like, transcript variant X1
UHRF1-binding protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
glucosamine-6-phosphate isomerase, transcript variant X2
glucosamine-6-phosphate isomerase, transcript variant X1
glucosamine-6-phosphate isomerase isoform X2
glucosamine-6-phosphate isomerase isoform X1
regulator of telomere elongation helicase 1 homolog
T-complex protein 11-like protein 1, transcript variant X5
T-complex protein 11-like protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
T-complex protein 11-like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
T-complex protein 11-like protein 1, transcript variant X4
T-complex protein 11-like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
T-complex protein 11-like protein 1 isoform X1
T-complex protein 11-like protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
apoptosis-inducing factor 1, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
apoptosis-inducing factor 1, mitochondrial, transcript variant X1
apoptosis-inducing factor 1, mitochondrial isoform X1
apoptosis-inducing factor 1, mitochondrial isoform X2
TBC domain-containing protein kinase-like protein, transcript variant X1
TBC domain-containing protein kinase-like protein, transcript variant X2
TBC domain-containing protein kinase-like protein
dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex-like
succinate dehydrogenase assembly factor 2, mitochondrial-like
rab proteins geranylgeranyltransferase component A 1, transcript variant X2
rab proteins geranylgeranyltransferase component A 1, transcript variant X1
rab proteins geranylgeranyltransferase component A 1 isoform X2
rab proteins geranylgeranyltransferase component A 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124412290, transcript variant X2
uncharacterized LOC124412290, transcript variant X1
uncharacterized LOC124412290, transcript variant X3
uncharacterized protein LOC124412290 isoform X1
uncharacterized protein LOC124412290 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 106 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
kynurenine/alpha-aminoadipate aminotransferase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II subunit beta-like, transcript variant X1
calcium/calmodulin-dependent protein kinase type II subunit beta-like isoform X1
calcium/calmodulin-dependent protein kinase type II subunit beta-like, transcript variant X2
calcium/calmodulin-dependent protein kinase type II subunit beta-like isoform X2
U11/U12 small nuclear ribonucleoprotein 35 kDa protein-like
troponin T, skeletal muscle, transcript variant X2
troponin T, skeletal muscle, transcript variant X4
troponin T, skeletal muscle, transcript variant X1
troponin T, skeletal muscle, transcript variant X3
cytoplasmic dynein 2 heavy chain 1, transcript variant X3
cytoplasmic dynein 2 heavy chain 1, transcript variant X1
cytoplasmic dynein 2 heavy chain 1, transcript variant X2
cytoplasmic dynein 2 heavy chain 1 isoform X2
cytoplasmic dynein 2 heavy chain 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
sodium- and chloride-dependent glycine transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
NADH-cytochrome b5 reductase 2, transcript variant X1
NADH-cytochrome b5 reductase 2, transcript variant X3
NADH-cytochrome b5 reductase 2, transcript variant X2
NADH-cytochrome b5 reductase 2, transcript variant X4
NADH-cytochrome b5 reductase 2 isoform X1
NADH-cytochrome b5 reductase 2 isoform X2
NADH-cytochrome b5 reductase 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
dedicator of cytokinesis protein 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
dedicator of cytokinesis protein 7 isoform X2
dedicator of cytokinesis protein 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dedicator of cytokinesis protein 7 isoform X4
mitotic spindle assembly checkpoint protein MAD1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
dedicator of cytokinesis protein 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dedicator of cytokinesis protein 7, transcript variant X2
dedicator of cytokinesis protein 7 isoform X1
dedicator of cytokinesis protein 7, transcript variant X4
dedicator of cytokinesis protein 7 isoform X3
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X3
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase, transcript variant X1
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X2
probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase isoform X1
leucine-rich repeat-containing protein 70-like
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial
zinc transporter 1, transcript variant X2
zinc transporter 1, transcript variant X1
glutamate receptor ionotropic, delta-1, transcript variant X2
glutamate receptor ionotropic, delta-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 73% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat-containing protein 56
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
protein O-mannosyl-transferase Tmtc3-like, transcript variant X1
protein O-mannosyl-transferase Tmtc3-like, transcript variant X2
protein O-mannosyl-transferase Tmtc3-like isoform X1
protein O-mannosyl-transferase Tmtc3-like isoform X2
vascular endothelial growth factor receptor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 65% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
mast/stem cell growth factor receptor Kit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase-like, transcript variant X1
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase-like, transcript variant X2
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase-like, transcript variant X3
2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
insulin-like growth factor-binding protein complex acid labile subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 50% coverage of the annotated genomic feature by RNAseq alignments
mediator of RNA polymerase II transcription subunit 7
tyrosine-protein kinase Btk29A, transcript variant X1
tyrosine-protein kinase Btk29A isoform X1
tyrosine-protein kinase Btk29A, transcript variant X2
tyrosine-protein kinase Btk29A isoform X2
tyrosine-protein kinase Btk29A, transcript variant X3
tyrosine-protein kinase Btk29A isoform X3
CRAL-TRIO domain-containing protein C3H8.02
probable 39S ribosomal protein L23, mitochondrial
polyglutamylase complex subunit TTLL1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
polyglutamylase complex subunit TTLL1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polyglutamylase complex subunit TTLL1, transcript variant X3
polyglutamylase complex subunit TTLL1 isoform X1
polyglutamylase complex subunit TTLL1 isoform X3
polyglutamylase complex subunit TTLL1 isoform X2
low-density lipoprotein receptor-related protein 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124412437, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124412437, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC124412437 isoform X2
uncharacterized protein LOC124412437 isoform X1
protein mini spindles, transcript variant X2
protein mini spindles, transcript variant X1
protein mini spindles, transcript variant X3
protein mini spindles, transcript variant X4
transmembrane protein 165, transcript variant X2
transmembrane protein 165, transcript variant X1
soluble guanylate cyclase 88E, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
soluble guanylate cyclase 88E, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
soluble guanylate cyclase 88E, transcript variant X3
soluble guanylate cyclase 88E, transcript variant X5
soluble guanylate cyclase 88E, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
soluble guanylate cyclase 88E isoform X1
soluble guanylate cyclase 88E isoform X3
soluble guanylate cyclase 88E isoform X2
soluble guanylate cyclase 88E isoform X4
ETS-related transcription factor Elf-5-like, transcript variant X3
ETS-related transcription factor Elf-5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ETS-related transcription factor Elf-5-like, transcript variant X1
ETS-related transcription factor Elf-5-like, transcript variant X2
ETS-related transcription factor Elf-5-like isoform X3
ETS-related transcription factor Elf-5-like isoform X4
ETS-related transcription factor Elf-5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
phosphoribosylformylglycinamidine synthase
mediator of RNA polymerase II transcription subunit 25, transcript variant X1
mediator of RNA polymerase II transcription subunit 25, transcript variant X2
mediator of RNA polymerase II transcription subunit 25 isoform X2
mediator of RNA polymerase II transcription subunit 25 isoform X1
WD repeat domain phosphoinositide-interacting protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
WD repeat domain phosphoinositide-interacting protein 4-like, transcript variant X1
WD repeat domain phosphoinositide-interacting protein 4-like
39S ribosomal protein L22, mitochondrial
cell wall protein DAN4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cell wall protein DAN4, transcript variant X2
cell wall protein DAN4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cell wall protein DAN4, transcript variant X1
uncharacterized protein LOC124412300 isoform X1
uncharacterized protein LOC124412300 isoform X3
uncharacterized protein LOC124412300 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mitochondrial inner membrane protease subunit 1, transcript variant X2
mitochondrial inner membrane protease subunit 1 isoform X2
mitochondrial inner membrane protease subunit 1, transcript variant X1
mitochondrial inner membrane protease subunit 1 isoform X1
beta-1,4-mannosyltransferase egh, transcript variant X2
beta-1,4-mannosyltransferase egh, transcript variant X1
uncharacterized LOC124412148, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC124412148, transcript variant X1
uncharacterized LOC124412148, transcript variant X4
uncharacterized LOC124412148, transcript variant X3
uncharacterized protein LOC124412148 isoform X2
uncharacterized protein LOC124412148 isoform X1
uncharacterized protein LOC124412148 isoform X3
gamma-tubulin complex component 2-like, transcript variant X2
gamma-tubulin complex component 2-like, transcript variant X1
gamma-tubulin complex component 2-like, transcript variant X3
gamma-tubulin complex component 2-like isoform X1
gamma-tubulin complex component 2-like isoform X2
transient receptor potential cation channel protein painless
leucine-rich repeat extensin-like protein 5, transcript variant X6
leucine-rich repeat extensin-like protein 5, transcript variant X8
leucine-rich repeat extensin-like protein 5, transcript variant X7
leucine-rich repeat extensin-like protein 5, transcript variant X1
leucine-rich repeat extensin-like protein 5, transcript variant X3
leucine-rich repeat extensin-like protein 5, transcript variant X5
leucine-rich repeat extensin-like protein 5, transcript variant X2
leucine-rich repeat extensin-like protein 5, transcript variant X11
leucine-rich repeat extensin-like protein 5, transcript variant X4
leucine-rich repeat extensin-like protein 5, transcript variant X9
leucine-rich repeat extensin-like protein 5, transcript variant X10
leucine-rich repeat extensin-like protein 5 isoform X11
N-acetylglucosamine-6-phosphate deacetylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 2% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 15% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
centrosomal protein of 135 kDa, transcript variant X3
centrosomal protein of 135 kDa, transcript variant X1
centrosomal protein of 135 kDa, transcript variant X2
centrosomal protein of 135 kDa isoform X3
centrosomal protein of 135 kDa isoform X1
centrosomal protein of 135 kDa isoform X2
uncharacterized LOC124412795, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124412795, transcript variant X1
uncharacterized LOC124412795, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
putative protein FAM10A4, transcript variant X3
putative protein FAM10A4, transcript variant X2
putative protein FAM10A4, transcript variant X1
uncharacterized protein LOC124412269 isoform X2
uncharacterized protein LOC124412269 isoform X1
N-alpha-acetyltransferase 15, NatA auxiliary subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
DNA-directed RNA polymerase III subunit RPC3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
transcription factor Sox-13, transcript variant X3
transcription factor Sox-13, transcript variant X2
transcription factor Sox-13, transcript variant X1
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X4
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X2
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X1
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X3
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X3
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X2
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X1
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X5
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X5
transmembrane 7 superfamily member 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
transmembrane 7 superfamily member 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
transmembrane 7 superfamily member 3-like isoform X1
transmembrane 7 superfamily member 3-like isoform X2
paired box protein Pax-6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
paired box protein Pax-6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 43% coverage of the annotated genomic feature by RNAseq alignments
torso-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
torso-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
torso-like protein, transcript variant X2
ubiquitin-like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ubiquitin-like protein 3, transcript variant X1
cleavage and polyadenylation specificity factor subunit 6, transcript variant X1
cleavage and polyadenylation specificity factor subunit 6, transcript variant X2
cleavage and polyadenylation specificity factor subunit 6, transcript variant X4
cleavage and polyadenylation specificity factor subunit 6, transcript variant X3
cleavage and polyadenylation specificity factor subunit 6, transcript variant X5
cleavage and polyadenylation specificity factor subunit 6 isoform X1
cleavage and polyadenylation specificity factor subunit 6 isoform X2
cleavage and polyadenylation specificity factor subunit 6 isoform X4
cleavage and polyadenylation specificity factor subunit 6 isoform X3
cleavage and polyadenylation specificity factor subunit 6 isoform X5
Hermansky-Pudlak syndrome 5 protein homolog, transcript variant X1
Hermansky-Pudlak syndrome 5 protein homolog, transcript variant X2
Hermansky-Pudlak syndrome 5 protein homolog isoform X1
Hermansky-Pudlak syndrome 5 protein homolog isoform X2
probable cytochrome P450 301a1, mitochondrial, transcript variant X3
probable cytochrome P450 301a1, mitochondrial, transcript variant X2
probable cytochrome P450 301a1, mitochondrial, transcript variant X1
probable cytochrome P450 301a1, mitochondrial
probable cytochrome P450 49a1, transcript variant X1
probable cytochrome P450 49a1, transcript variant X2
probable cytochrome P450 49a1, transcript variant X3
probable cytochrome P450 301a1, mitochondrial isoform X1
probable cytochrome P450 49a1 isoform X2
probable cytochrome P450 49a1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC124412372, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC124412372, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized protein LOC124412372 isoform X2
uncharacterized protein LOC124412372 isoform X1
protein king tubby 1, transcript variant X1
protein king tubby 1, transcript variant X2
protein king tubby 1, transcript variant X3
FK506-binding protein 59, transcript variant X2
FK506-binding protein 59, transcript variant X3
FK506-binding protein 59, transcript variant X1
FK506-binding protein 59, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
cytoplasmic FMR1-interacting protein, transcript variant X2
cytoplasmic FMR1-interacting protein, transcript variant X1
cytoplasmic FMR1-interacting protein isoform X2
cytoplasmic FMR1-interacting protein isoform X1
FHIP family protein AAEL005291-like, transcript variant X4
FHIP family protein AAEL005291-like, transcript variant X2
FHIP family protein AAEL005291-like, transcript variant X3
FHIP family protein AAEL005291-like, transcript variant X1
FHIP family protein AAEL005291-like isoform X4
FHIP family protein CPIJ015043-like isoform X2
FHIP family protein CPIJ015043-like isoform X3
FHIP family protein CPIJ015043-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X3
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X2
4-hydroxybenzoate polyprenyltransferase, mitochondrial, transcript variant X1
4-hydroxybenzoate polyprenyltransferase, mitochondrial isoform X3
4-hydroxybenzoate polyprenyltransferase, mitochondrial isoform X2
4-hydroxybenzoate polyprenyltransferase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heart- and neural crest derivatives-expressed protein 1-like
la-related protein 1B, transcript variant X2
la-related protein 1B, transcript variant X1
la-related protein 1B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
AP-2 complex subunit alpha, transcript variant X1
AP-2 complex subunit alpha, transcript variant X2
tumor necrosis factor receptor superfamily member 4-like, transcript variant X1
tumor necrosis factor receptor superfamily member 4-like, transcript variant X2
tumor necrosis factor receptor superfamily member 4-like isoform X1
tumor necrosis factor receptor superfamily member 4-like isoform X2
tumor necrosis factor receptor superfamily member 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-crystallin A chain, transcript variant X1
alpha-crystallin A chain, transcript variant X2
uncharacterized LOC124412419, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
uncharacterized LOC124412419, transcript variant X1
uncharacterized protein LOC124412419 isoform X1
uncharacterized protein LOC124412419 isoform X2
uncharacterized LOC124412667, transcript variant X1
uncharacterized LOC124412667, transcript variant X2
branched-chain-amino-acid aminotransferase, cytosolic
proton channel OtopLc-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
proton channel OtopLc-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
histone-lysine N-methyltransferase Suv4-20, transcript variant X3
histone-lysine N-methyltransferase Suv4-20, transcript variant X4
histone-lysine N-methyltransferase Suv4-20, transcript variant X1
histone-lysine N-methyltransferase Suv4-20, transcript variant X2
histone-lysine N-methyltransferase Suv4-20 isoform X2
histone-lysine N-methyltransferase Suv4-20 isoform X1
phospholipid-transporting ATPase VD, transcript variant X1
phospholipid-transporting ATPase VD, transcript variant X3
phospholipid-transporting ATPase VD, transcript variant X2
phospholipid-transporting ATPase VD isoform X1
phospholipid-transporting ATPase VD isoform X2
phospholipid-transporting ATPase VD isoform X3
uncharacterized LOC124412452, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124412452, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
caseinolytic peptidase B protein homolog, transcript variant X2
caseinolytic peptidase B protein homolog, transcript variant X1
caseinolytic peptidase B protein homolog isoform X2
caseinolytic peptidase B protein homolog isoform X1
97 kDa heat shock protein, transcript variant X1
97 kDa heat shock protein, transcript variant X2
vacuolar ATPase assembly integral membrane protein VMA21 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
vacuolar ATPase assembly integral membrane protein VMA21 homolog, transcript variant X1
vacuolar ATPase assembly integral membrane protein VMA21 homolog
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial, transcript variant X2
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial isoform X2
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
brain tumor protein, transcript variant X3
brain tumor protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
brain tumor protein, transcript variant X1
nuclear pore complex protein Nup58, transcript variant X5
nuclear pore complex protein Nup58, transcript variant X3
nuclear pore complex protein Nup58, transcript variant X2
nuclear pore complex protein Nup58, transcript variant X4
nuclear pore complex protein Nup58, transcript variant X1
nuclear pore complex protein Nup58, transcript variant X8
nuclear pore complex protein Nup58, transcript variant X7
nuclear pore complex protein Nup58, transcript variant X6
nuclear pore complex protein Nup58, transcript variant X9
nuclear pore complex protein Nup58 isoform X1
nuclear pore complex protein Nup58 isoform X3
nuclear pore complex protein Nup58 isoform X2
nuclear pore complex protein Nup58 isoform X5
nuclear pore complex protein Nup58 isoform X4
nuclear pore complex protein Nup58 isoform X6
uncharacterized LOC124412347, transcript variant X2
uncharacterized LOC124412347, transcript variant X1
uncharacterized protein LOC124412347 isoform X1
uncharacterized protein LOC124412347 isoform X2
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
WD repeat-containing protein 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
WD repeat-containing protein 19 isoform X1
WD repeat-containing protein 19, transcript variant X2
WD repeat-containing protein 19 isoform X2
membrane-associated progesterone receptor component 1
histone lysine acetyltransferase CREBBP, transcript variant X1
histone lysine acetyltransferase CREBBP, transcript variant X2
histone acetyltransferase p300 isoform X1
histone lysine acetyltransferase CREBBP isoform X2
histone lysine acetyltransferase CREBBP-like, transcript variant X4
histone lysine acetyltransferase CREBBP-like, transcript variant X1
histone lysine acetyltransferase CREBBP-like, transcript variant X2
histone lysine acetyltransferase CREBBP-like, transcript variant X5
histone lysine acetyltransferase CREBBP-like, transcript variant X3
histone lysine acetyltransferase CREBBP-like isoform X3
ubiquitin carboxyl-terminal hydrolase 48-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 48-like isoform X2
ubiquitin carboxyl-terminal hydrolase 48-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 48-like isoform X1
mitotic spindle assembly checkpoint protein MAD2B, transcript variant X2
mitotic spindle assembly checkpoint protein MAD2B, transcript variant X1
mitotic spindle assembly checkpoint protein MAD2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
zinc finger protein 853-like, transcript variant X1
zinc finger protein 853-like, transcript variant X3
zinc finger protein 853-like, transcript variant X2
uncharacterized LOC124412252, transcript variant X1
uncharacterized LOC124412252, transcript variant X2
uncharacterized LOC124412150, transcript variant X3
uncharacterized LOC124412150, transcript variant X1
uncharacterized LOC124412150, transcript variant X4
uncharacterized LOC124412150, transcript variant X2
uncharacterized protein LOC124412150 isoform X2
uncharacterized protein LOC124412150 isoform X1
uncharacterized protein LOC124412150 isoform X3
ly6/PLAUR domain-containing protein 6B-like, transcript variant X2
ly6/PLAUR domain-containing protein 6B-like, transcript variant X1
ly6/PLAUR domain-containing protein 6B-like
glycylpeptide N-tetradecanoyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
OTU domain-containing protein 7B-like, transcript variant X2
OTU domain-containing protein 7B-like, transcript variant X1
protein Fe65 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
protein Fe65 homolog, transcript variant X1
protein Fe65 homolog, transcript variant X5
protein Fe65 homolog, transcript variant X4
protein Fe65 homolog, transcript variant X6
protein Fe65 homolog, transcript variant X3
protein Fe65 homolog, transcript variant X8
protein Fe65 homolog, transcript variant X7
serine/threonine-protein kinase PLK4, transcript variant X1
serine/threonine-protein kinase PLK4, transcript variant X2
serine/threonine-protein kinase PLK4 isoform X1
serine/threonine-protein kinase PLK4 isoform X2
AF4/FMR2 family member lilli, transcript variant X1
AF4/FMR2 family member lilli, transcript variant X2
AF4/FMR2 family member lilli, transcript variant X3
AF4/FMR2 family member lilli, transcript variant X4
AF4/FMR2 family member lilli, transcript variant X5
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
NEDD4 family-interacting protein 1, transcript variant X2
NEDD4 family-interacting protein 1, transcript variant X1
NEDD4 family-interacting protein 1, transcript variant X3
NEDD4 family-interacting protein 1-like isoform X1
NEDD4 family-interacting protein 1 isoform X3
NEDD4 family-interacting protein 1-like isoform X2
pelle-like serine/threonine-protein kinase pik-1
ATP-binding cassette sub-family B member 6, transcript variant X1
ATP-binding cassette sub-family B member 6, transcript variant X2
ATP-binding cassette sub-family B member 6
polyamine-transporting ATPase 13A3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
polyamine-transporting ATPase 13A3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
polyamine-transporting ATPase 13A3-like, transcript variant X3
delta-sarcoglycan, transcript variant X1
delta-sarcoglycan, transcript variant X2
delta-sarcoglycan, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase BRE1-like, transcript variant X1
E3 ubiquitin-protein ligase BRE1-like, transcript variant X2
E3 ubiquitin-protein ligase BRE1-like, transcript variant X3
E3 ubiquitin-protein ligase BRE1-like, transcript variant X4
E3 ubiquitin-protein ligase BRE1-like isoform X1
E3 ubiquitin-protein ligase BRE1-like isoform X2
E3 ubiquitin-protein ligase BRE1-like isoform X3
E3 ubiquitin-protein ligase BRE1-like isoform X4
uncharacterized LOC124412200, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124412200, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC124412200 isoform X2
uncharacterized protein LOC124412200 isoform X1
general transcription factor IIH subunit 1
uncharacterized LOC124412403, transcript variant X2
uncharacterized protein LOC124412403 isoform X2
uncharacterized LOC124412403, transcript variant X1
uncharacterized LOC124412403, transcript variant X3
uncharacterized protein LOC124412403 isoform X3
uncharacterized protein LOC124412403 isoform X1
programmed cell death protein 6, transcript variant X2
programmed cell death protein 6, transcript variant X1
programmed cell death protein 6 isoform X2
programmed cell death protein 6 isoform X1
zinc finger protein 143-like, transcript variant X3
zinc finger protein 143-like, transcript variant X1
zinc finger protein 143-like, transcript variant X4
zinc finger protein 143-like, transcript variant X5
zinc finger protein 143-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
protein lin-9 homolog, transcript variant X1
protein lin-9 homolog, transcript variant X2
protein lin-9 homolog, transcript variant X4
protein lin-9 homolog, transcript variant X3
uncharacterized LOC124412471, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124412471, transcript variant X1
uncharacterized protein LOC124412471 isoform X1
uncharacterized protein LOC124412471 isoform X2
LIM domain only protein 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LIM domain only protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LIM domain only protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LIM domain only protein 3-like isoform X1
LIM domain only protein 3-like isoform X2
GRB2-associated-binding protein 2, transcript variant X2
GRB2-associated-binding protein 2, transcript variant X1
GRB2-associated-binding protein 2 isoform X2
GRB2-associated-binding protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tudor domain-containing protein 3, transcript variant X4
tudor domain-containing protein 3, transcript variant X2
tudor domain-containing protein 3, transcript variant X3
tudor domain-containing protein 3, transcript variant X1
tudor domain-containing protein 3 isoform X4
tudor domain-containing protein 3 isoform X3
tudor domain-containing protein 3 isoform X2
tudor domain-containing protein 3 isoform X1
uncharacterized LOC124412679, transcript variant X1
uncharacterized LOC124412679, transcript variant X4
uncharacterized LOC124412679, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124412679, transcript variant X3
uncharacterized LOC124412679, transcript variant X5
uncharacterized LOC124412679, transcript variant X2
uncharacterized LOC124412679, transcript variant X6
uncharacterized LOC124412679, transcript variant X7
uncharacterized LOC124412679, transcript variant X8
uncharacterized protein LOC124412679 isoform X1
uncharacterized protein LOC124412679 isoform X3
uncharacterized protein LOC124412679 isoform X5
uncharacterized protein LOC124412679 isoform X2
uncharacterized protein LOC124412679 isoform X4
uncharacterized protein LOC124412679 isoform X6
uncharacterized protein LOC124412679 isoform X7
uncharacterized protein LOC124412679 isoform X8
uncharacterized protein LOC124412679 isoform X10
uncharacterized LOC124412679, transcript variant X9
uncharacterized protein LOC124412679 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
pollen-specific leucine-rich repeat extensin-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
glycine-rich cell wall structural protein
polyamine-transporting ATPase 13A3, transcript variant X2
polyamine-transporting ATPase 13A3, transcript variant X1
polyamine-transporting ATPase 13A3 isoform X2
polyamine-transporting ATPase 13A3 isoform X1
probable phospholipid-transporting ATPase IA, transcript variant X2
probable phospholipid-transporting ATPase IA, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable phospholipid-transporting ATPase IA isoform X2
probable phospholipid-transporting ATPase IA, transcript variant X8
probable phospholipid-transporting ATPase IA, transcript variant X1
probable phospholipid-transporting ATPase IA, transcript variant X7
probable phospholipid-transporting ATPase IA, transcript variant X4
probable phospholipid-transporting ATPase IA, transcript variant X9
probable phospholipid-transporting ATPase IA, transcript variant X13
probable phospholipid-transporting ATPase IA isoform X5
probable phospholipid-transporting ATPase IA isoform X6
probable phospholipid-transporting ATPase IA isoform X1
probable phospholipid-transporting ATPase IA isoform X3
probable phospholipid-transporting ATPase IA isoform X7
probable phospholipid-transporting ATPase IA, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable phospholipid-transporting ATPase IA, transcript variant X5
probable phospholipid-transporting ATPase IA isoform X4
probable phospholipid-transporting ATPase IA, transcript variant X10
probable phospholipid-transporting ATPase IA, transcript variant X11
probable phospholipid-transporting ATPase IA isoform X8
probable phospholipid-transporting ATPase IA, transcript variant X12
probable phospholipid-transporting ATPase IA isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
neuronal membrane glycoprotein M6-b, transcript variant X2
neuronal membrane glycoprotein M6-b, transcript variant X1
neuronal membrane glycoprotein M6-b isoform X2
neuronal membrane glycoprotein M6-a isoform X1
putative sodium-coupled neutral amino acid transporter 11, transcript variant X1
putative sodium-coupled neutral amino acid transporter 11, transcript variant X3
putative sodium-coupled neutral amino acid transporter 11, transcript variant X2
putative sodium-coupled neutral amino acid transporter 11 isoform X2
putative sodium-coupled neutral amino acid transporter 11 isoform X1
putative sodium-coupled neutral amino acid transporter 11 isoform X3
C-mannosyltransferase dpy-19, transcript variant X1
C-mannosyltransferase dpy-19, transcript variant X2
uncharacterized LOC124412142, transcript variant X1
uncharacterized LOC124412142, transcript variant X2
uncharacterized protein LOC124412142 isoform X1
uncharacterized protein LOC124412142 isoform X2
uncharacterized LOC124412263, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
uncharacterized LOC124412263, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC124412263, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized protein LOC124412263 isoform X1
uncharacterized protein LOC124412263 isoform X2
uncharacterized protein LOC124412263 isoform X3
protein jim lovell-like, transcript variant X1
protein jim lovell-like, transcript variant X2
tetratricopeptide repeat protein 12-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ephrin type-A receptor 4, transcript variant X1
ephrin type-A receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
zinc finger BED domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns